Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic developments in pancreatic cancer
Zilun Hu, Eileen M. O’Reilly
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 1, pp. 7-24
Closed Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Role of glycosylation-related gene MGAT1 in pancreatic ductal adenocarcinoma
Lai Jiang, Jie Liu, Shengke Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Next-generation therapies for pancreatic cancer
Conor Buckley, Eileen M. O’Reilly
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 1-3, pp. 55-72
Open Access | Times Cited: 12
Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic cancer therapy
Xingwei Li, Haiping Zhong, Shujing Zheng, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 444-457
Closed Access | Times Cited: 10
Precision treatment of pancreatic ductal adenocarcinoma
Hongyun Wei, He Ren
Cancer Letters (2024) Vol. 585, pp. 216636-216636
Closed Access | Times Cited: 8
Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via exosomes in gastrointestinal tumors
Longyang Cao, Hong Ouyang
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 8
GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer
Yujing Xuan, Wenyi Yan, Rui Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Rational Design of Metal–Organic Frameworks for Pancreatic Cancer Therapy: from Machine Learning Screening to In Vivo Efficacy
Francesca Melle, Dhruv Menon, João Conniot, et al.
Advanced Materials (2025)
Open Access | Times Cited: 1
5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation
Danjun Song, Zhou Zhang, Jiaping Zheng, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment
Hassan Sadozai, Animesh Acharjee, Hateem Zafar Kayani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Illuminating the immunological landscape: mitochondrial gene defects in pancreatic cancer through a multiomics lens
Hao Chi, Lanqian Su, Yalan Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
Chiara Musiu, Francesca Lupo, Antonio De Agostini, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma
Gurkaranjot Singh, Drew Kutcher, Rajeshwar Lally, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2101-2101
Open Access | Times Cited: 5
Dissecting the anti-pancreatic cancer mechanism of gold nanorods mediate photothermal therapy through quantitative proteomics analysis
Zhen Sun, Feng Zhang, Xin-Yi Liu, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 747, pp. 151288-151288
Closed Access
Metastatic patterns stratify patients with pancreatic cancer
John Nguyen, Francisco Sánchez-Vega
Nature Cancer (2025)
Closed Access
Identification and characterization of tumor and stromal derived liquid biopsy analytes in pancreatic ductal adenocarcinoma
Julian Götze, K. Meißner, Thais Pereira‐Veiga, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Overcoming immunotherapeutic drug resistance in pancreatic and colon cancers
Mario Tavakoli, Hasan Raza, Dirin Ukwade, et al.
Elsevier eBooks (2025), pp. 305-324
Closed Access
The nucleolin antagonist N6L and paclitaxel combination treatment could be a new promising therapeutic strategy for pancreatic ductal adenocarcinoma therapy
Fabrice Raineri, Linda LaRue, C. Cojocaru, et al.
European Journal of Pharmacology (2025), pp. 177310-177310
Closed Access
A safe haven for cancer cells: tumor plus stroma control by DYRK1B
Miriam Ems, Anna Brichkina, Matthias Lauth
Oncogene (2025)
Open Access
NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
Youlong Zhu, Zongze Qi, Shujing Zu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Lactate-associated gene MCU promotes the proliferation, migration, and invasion of pancreatic adenocarcinoma
Yuhang Chen, Fenglin Zhang, Shengyuan Dai, et al.
Research Square (Research Square) (2025)
Closed Access
FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance
Li Zhang, Fang Wei, Qihui Sun, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 3, pp. 1047-1064
Open Access
The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021
Weidong Yu, Danyi Zhou, Fanhao Meng, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
PD-L1 knockout or ZG16 overexpression inhibits PDAC progression and modulates TAM polarization
Hui Meng, Manman Nan, Yizhen Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy
Diana Peixoto, João M. J. M. Ravasco, Bárbara Blanco‐Fernandez, et al.
Materials Today Bio (2025) Vol. 31, pp. 101555-101555
Open Access
Page 1 - Next Page

Scroll to top